Quantcast
breaking news

FDA Issues Warning About Popular Heartburn Drugs

By: Charlotte Ames
Updated: May 25, 2010

The F.D.A has issued a new warning about the safety of popular drugs for heartburn and acid reflux disease.  The agency said the medications called Proton Pump Inhibitors (PPIs) can possibly increase the risk of hip, wrist, and spine fractures and it will require the drug labels to be revised to include this warning.

 The greatest increased risk for these fractures was seen in people who receive high doses of these medications or use them for a year or longer.

Proton pump inhibitors work by reducing the amount of acid in the stomach. Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex, and Vimovo are available by prescription to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus.

Prilosec OTC, Zegerid OTC, and Prevacid 24HR are sold over-the-counter for the treatment of frequent heartburn.

The agency advised patients not to stop taking the medications unless they're told to do so by their healthcare professional.  
 
Go here for more information.



Comments

Readers Feel...

hello
Related Content

A fire causes $100,000 in damage at home. Cause under investigation....

Also pleads guilty to drug charges from separate incident...

Girl rushed to hospital...

A car hits a utility pole knocking out power for hundreds of residents....

Police said the couple was awakened around 6 am by the men breaking in. ...

Area school district offers free meals to those 18 and under....

Ultralight aircraft crashes into trees....

Watch your WeAreCentralPA.com Sports Webcast, with your latest headlines across Central Pennsylvania....

No new school taxes in Altoona for the coming year....

Altoona police were busy handling one DUI suspect who fought his arrest....

 
 

Visit Snare and Associates
Do you think smoking should be banned from bars?
 

Sponsored By



 
 
©1998 - 2013 Wearecentralpa.com
Nexstar Broadcasting, Inc.
All Rights Reserved